The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Iron oxide nanoparticles for targeted cancer imaging and diagnostics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Monodisperse MFe2O4 (M = Fe, Co, Mn) Nanoparticles
Sun, S., Zeng, H., Robinson, D. B., Raoux, S., Rice, P. M., Wang, S. X., & Li, G. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0380852 · Cited by 3,441
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Preparation of aqueous magnetic liquids in alkaline and acidic media
Massart, R. (1981) · IEEE Transactions on Magnetics · doi:10.1109/tmag.1981.1061188 · Cited by 2,817
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
Jayasena, S. D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1628 · Cited by 2,144
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc727 · Cited by 1,777
Neuberger, T., Schöpf, B., Hofmann, H., Hofmann, M., & von Rechenberg, B. (2005) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2005.01.064 · Cited by 1,728
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
Synthesis, properties, and applications of magnetic iron oxide nanoparticles
Teja, A. S., & Koh, P.-Y. (2009) · Progress in Crystal Growth and Characterization of Materials · doi:10.1016/j.pcrysgrow.2008.08.003 · Cited by 1,495
Targeted drug delivery via the folate receptor
Sudimack, J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,474
Recent advances in iron oxide nanocrystal technology for medical imaging☆
COROT, C., ROBERT, P., IDEE, J., & PORT, M. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.013 · Cited by 1,465
Wang, Y.-X. J., Hussain, S. M., & Krestin, G. P. (2001) · European Radiology · doi:10.1007/s003300100908 · Cited by 1,381
Frey, N. A., Peng, S., Cheng, K., & Sun, S. (2009) · Chemical Society Reviews · doi:10.1039/b815548h · Cited by 1,200
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., & Kamen, B. A. (1992) · PubMed · Cited by 1,011
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Self-citationNanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
Thorek, D. L. J., Chen, A. K., Czupryna, J., & Tsourkas, A. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9002-7 · Cited by 772
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
Qiao, R., Yang, C., & Gao, M. (2009) · Journal of Materials Chemistry · doi:10.1039/b902394a · Cited by 685
Characterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applications
Cheng, F.-Y., Su, C.-H., Yang, Y.-S., Yeh, C.-S., Tsai, C.-Y., Wu, C.-L., Wu, M.-T., & Shieh, D.-B. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.03.016 · Cited by 668
Self-citationBinding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain
Nord, K., Gunneriusson, E., Ringdahl, J., Ståhl, S., Uhlén, M., & Nygren, P.-Å. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-772 · Cited by 662
Daniels, T. R., Delgado, T., Rodriguez, J. A., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 634
Gupta, A. K., & Wells, S. (2004) · IEEE Transactions on Nanobioscience · doi:10.1109/tnb.2003.820277 · Cited by 634
Lupold, S. E., Hicke, B. J., Lin, Y. H., & Coffey, D. S. (2002) · PubMed · Cited by 566
Transferrin receptors in human tissues: their distribution and possible clinical relevance.
Gatter, K. C., Brown, G., Trowbridge, I. S., Woolston, R. E., & Mason, D. Y. (1983) · Journal of Clinical Pathology · doi:10.1136/jcp.36.5.539 · Cited by 531
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels, T. R., Delgado, T., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 518
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
Wesolowski, J., Alzogaray, V., Reyelt, J., Unger, M., Juarez, K., Urrutia, M., Cauerhff, A., Danquah, W., Rissiek, B., Scheuplein, F., et al. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0116-7 · Cited by 513
Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
Stark, D. D., Weissleder, R., Elizondo, G., Hahn, P. F., Saini, S., Todd, L. E., Wittenberg, J., & Ferrucci, J. T. (1988) · Radiology · doi:10.1148/radiology.168.2.3393649 · Cited by 512
Sonvico, F., Mornet, S., Vasseur, S., Dubernet, C., Jaillard, D., Degrouard, J., Hoebeke, J., Duguet, E., Colombo, P., & Couvreur, P. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050050z · Cited by 484
Selection of Aptamers for Molecular Recognition and Characterization of Cancer Cells
Tang, Z., Shangguan, D., Wang, K., Shi, H., Sefah, K., Mallikratchy, P., Chen, H. W., Li, Y., & Tan, W. (2007) · Analytical Chemistry · doi:10.1021/ac070189y · Cited by 479
Targeted nanoparticles for cancer therapy
Gu, F. X., Karnik, R., Wang, A. Z., Alexis, F., Levy-Nissenbaum, E., Hong, S., Langer, R. S., & Farokhzad, O. C. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70083-x · Cited by 478
Self-citationNoguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Ciechanover, A., Schwartz, A. L., Dautry-Varsat, A., & Lodish, H. F. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44551-0 · Cited by 434
Aptamer-Conjugated Nanoparticles for Selective Collection and Detection of Cancer Cells
Herr, J. K., Smith, J. E., Medley, C. D., Shangguan, D., & Tan, W. (2006) · Analytical Chemistry · doi:10.1021/ac052015r · Cited by 431
Xie, J., Chen, K., Lee, H.-Y., Xu, C., Hsu, A. R., Peng, S., Chen, X., & Sun, S. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802003h · Cited by 419
Gupta, A. K., & Curtis, A. S. G. (2004) · Journal of Materials Science: Materials in Medicine · doi:10.1023/b:jmsm.0000021126.32934.20 · Cited by 402
Targeted Nanoparticles for Cancer Therapy
Reddy, G. S. N. (2021) · Journal of Bioanalysis & Biomedicine · Cited by 401
Multivalent Effects of RGD Peptides Obtained by Nanoparticle Display
Montet, X., Funovics, M., Montet-Abou, K., Weissleder, R., & Josephson, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060515m · Cited by 388
Efficient Cancer Therapy with a Nanobody-Based Conjugate
Cortez-Retamozo, V., Backmann, N., Senter, P. D., Wernery, U., De Baetselier, P., Muyldermans, S., & Revets, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3935 · Cited by 382
Folate-mediated targeting: from diagnostics to drug and gene delivery
Leamon, C. P., & Low, P. S. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01594-4 · Cited by 375
Sun, C., Sze, R., & Zhang, M. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30781 · Cited by 373
Nanomedicines and nanotoxicology: some physiological principles
Garnett, M. C., & Kallinteri, P. (2006) · Occupational Medicine · doi:10.1093/occmed/kql052 · Cited by 352
Artemov, D., Mori, N., Okollie, B., & Bhujwalla, Z. M. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10406 · Cited by 351
The folate receptor: What does it promise in tissue-targeted therapeutics?
Salazar, M. D., & Ratnam, M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9048-0 · Cited by 350
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Roovers, R. C., Laeremans, T., Huang, L., De Taeye, S., Verkleij, A. J., Revets, H., de Haard, H. J., & van Bergen en Henegouwen, P. M. P. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0180-4 · Cited by 346
Aptamer-Conjugated Nanoparticles for the Collection and Detection of Multiple Cancer Cells
Smith, J. E., Medley, C. D., Tang, Z., Shangguan, D., Lofton, C., & Tan, W. (2007) · Analytical Chemistry · doi:10.1021/ac062151b · Cited by 343
Tumoral Distribution of Long-circulating Dextran-coated Iron Oxide Nanoparticles in a Rodent Model
Moore, A., Marecos, E., Bogdanov, A., & Weissleder, R. (2000) · Radiology · doi:10.1148/radiology.214.2.r00fe19568 · Cited by 343
Magnetically labeled cells can be detected by MR imaging
Weissleder, R., Cheng, H., Bogdanova, A., & Bogdanov, A. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070140 · Cited by 336
Progress in functionalization of magnetic nanoparticles for applications in biomedicine
Berry, C. C. (2009) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/42/22/224003 · Cited by 336
Zhang, C., Jugold, M., Woenne, E. C., Lammers, T., Morgenstern, B., Mueller, M. M., Zentgraf, H., Bock, M., Eisenhut, M., Semmler, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1668 · Cited by 336
Identification of Liver Cancer-Specific Aptamers Using Whole Live Cells
Shangguan, D., Meng, L., Cao, Z. C., Xiao, Z., Fang, X., Li, Y., Cardona, D., Witek, R. P., Liu, C., & Tan, W. (2008) · Analytical Chemistry · doi:10.1021/ac701962v · Cited by 316
Song, H.-T., Choi, J.-S., Huh, Y.-M., Kim, S., Jun, Y.-W., Suh, J.-S., & Cheon, J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051833y · Cited by 304
Cancer Cell Targeting Using Multiple Aptamers Conjugated on Nanorods
Huang, Y.-F., Chang, H.-T., & Tan, W. (2008) · Analytical Chemistry · doi:10.1021/ac702322j · Cited by 303
Synthesis, characterization and MRI application of dextran-coated Fe3O4 magnetic nanoparticles
Hong, R. Y., Feng, B., Chen, L. L., Liu, G. H., Li, H. Z., Zheng, Y., & Wei, D. G. (2008) · Biochemical Engineering Journal · doi:10.1016/j.bej.2008.07.009 · Cited by 298
Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells
Wang, S., & Low, P. S. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00236-8 · Cited by 295
Ligands for Mapping αvβ3-Integrin Expression in Vivo
Schottelius, M., Laufer, B., Kessler, H., & Wester, H.-J. (2009) · Accounts of Chemical Research · doi:10.1021/ar800243b · Cited by 294
Starch-Coated Superparamagnetic Nanoparticles as MR Contrast Agents
Kim, D. K., Mikhaylova, M., Wang, F. H., Kehr, J., Bjelke, B., Zhang, Y., Tsakalakos, T., & Muhammed, M. (2003) · Chemistry of Materials · doi:10.1021/cm031104m · Cited by 278
Zhang, J., Rana, S., Srivastava, R. S., & Misra, R. D. K. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2007.06.006 · Cited by 277
Wagner, E., Curiel, D., & Cotten, M. (1994) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(94)90008-6 · Cited by 275
Mallikaratchy, P., Tang, Z., Kwame, S., Meng, L., Shangguan, D., & Tan, W. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700026-mcp200 · Cited by 268
Irvine, D., Tuerk, C., & Gold, L. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90509-5 · Cited by 266
Qu, S., Yang, H., Ren, D., Kan, S., Zou, G., Li, D., & Li, M. (1999) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1999.6185 · Cited by 262
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
Moore, A., Weissleder, R., & Bogdanov, A. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070629 · Cited by 260
Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
Zhang, L., Radovic‐Moreno, A. F., Alexis, F., Gu, F. X., Basto, P. A., Bagalkot, V., Jon, S., Langer, R. S., & Farokhzad, O. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200700121 · Cited by 257
Self-citationEnochs, W. S., Harsh, G., Hochberg, F., & Weissleder, R. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199902)9:2<228::aid-jmri12>3.0.co;2-k · Cited by 253
Nanoparticle Imaging of Integrins on Tumor Cells
Montet, X., Montet-Abou, K., Reynolds, F., Weissleder, R., & Josephson, L. (2006) · Neoplasia · doi:10.1593/neo.05769 · Cited by 251
Ma, H.-L., Qi, X.-R., Maitani, Y., & Nagai, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.006 · Cited by 246
Choi, H., Choi, S. R., Zhou, R., Kung, H. F., & Chen, I.-W. (2004) · Academic Radiology · doi:10.1016/j.acra.2004.04.018 · Cited by 240
Briley-Saebo, K., Bj�rnerud, A., Grant, D., Ahlstrom, H., Berg, T., & Kindberg, G. M. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0884-8 · Cited by 235
Imai, Y., Murakami, T., Yoshida, S., Nishikawa, M., Ohsawa, M., Tokunaga, K., Murata, M., Shibata, K., Zushi, S., Kurokawa, M., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.9113 · Cited by 223
The Transferrin Receptor: A Potential Molecular Imaging Marker for Human Cancer
Högemann-Savellano, D., Bos, E., Blondet, C., Sato, F., Abe, T., Josephson, L., Weissleder, R., Gaudet, J., Sgroi, D., Peters, P. J., et al. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80034-9 · Cited by 201
Willuda, J., Honegger, A., Waibel, R., Schubiger, P. A., Stahel, R. A., Zangemeister‐Wittke, U., & Plückthun, A. (1999) · PubMed · Cited by 200
Ryschich, E., Huszty, G., Knaebel, H. P., Hartel, M., Büchler, M. W., & Schmidt, J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.036 · Cited by 199
Targeted Paclitaxel by Conjugation to Iron Oxide and Gold Nanoparticles
Hwu, J. R., Lin, Y. S., Josephrajan, T., Hsu, M.-H., Cheng, F.-Y., Yeh, C.-S., Su, W.-C., & Shieh, D.-B. (2009) · Journal of the American Chemical Society · doi:10.1021/ja804947u · Cited by 199
Self-citationSynthesis of highly stable folic acid conjugated magnetite nanoparticles for targeting cancer cells
Mohapatra, S., Mallick, S. K., Maiti, T. K., Ghosh, S. K., & Pramanik, P. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/38/385102 · Cited by 194
Weissleder, R., Lee, A. S., Khaw, B. A., Shen, T., & Brady, T. J. (1992) · Radiology · doi:10.1148/radiology.182.2.1732953 · Cited by 186
Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells
Zhao, Z., Xu, L., Shi, X., Tan, W., Fang, X., & Shangguan, D. (2009) · The Analyst · doi:10.1039/b904476k · Cited by 179
How molecular imaging is speeding up antiangiogenic drug development
Cai, W., Rao, J., Gambhir, S. S., & Chen, X. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0395 · Cited by 175
Landmark, K. J., DiMaggio, S., Ward, J., Kelly, C., Vogt, S., Hong, S., Kotlyar, A., Myc, A., Thomas, T. P., Penner-Hahn, J. E., et al. (2008) · ACS Nano · doi:10.1021/nn800034w · Cited by 172
Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects
Lu, Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00215-3 · Cited by 172
HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy
Alexis, F., Basto, P., Levy‐Nissenbaum, E., Radovic‐Moreno, A. F., Zhang, L., Pridgen, E., Wang, A. Z., Marein, S. L., Westerhof, K., Molnar, L. K., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800122 · Cited by 164
Kresse, M., Wagner, S., Pfefferer, D., Lawaczeck, R., Elste, V., & Semmler, W. (1998) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910400209 · Cited by 161
Tiefenauer, L., Kuehne, G., & Andres, R. Y. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00023a007 · Cited by 159
Shangguan, D., Cao, Z. C., Li, Y., & Tan, W. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.083246 · Cited by 159
Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging.
Weissleder, R., Lee, A. S., Fischman, A. J., Reimer, P., Shen, T. T., Wilkinson, R., Callahan, R. J., & Brady, T. J. (1991) · Radiology · doi:10.1148/radiology.181.1.1887040 · Cited by 153
Várallyay, P., Nesbit, G. M., Muldoon, L. L., Nixon, R. R., Delashaw, J. B., Cohen, J. I., Petrillo, A., Rink, D., & Neuwelt, E. A. (2002) · PubMed Central · Cited by 149
Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes
Cheng, F., Wang, S. P.-H., Su, C.-H., Tsai, T.-L., Wu, P., Shieh, D.-B., Chen, J., Hsieh, P. C. H., & Yeh, C. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.010 · Cited by 142
Self-citationBerry, C. C., Charles, S. W., Wells, S., Dalby, M. J., & Curtis, A. S. G. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.042 · Cited by 138
Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging.
Weissleder, R., Hahn, P. F., Stark, D. D., Elizondo, G., Saini, S., Todd, L. E., WITTENBERG, J., & Ferrucci, J. T. (1988) · Radiology · doi:10.1148/radiology.169.2.3174987 · Cited by 137
Yigit, M. V., Mazumdar, D., Kim, H., Lee, J. H., Odintsov, B. M., & Lu, Y. (2007) · ChemBioChem · doi:10.1002/cbic.200700323 · Cited by 136
Li, H., Xu, Y., Qi, X., Maitani, Y., & Nagai, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.036 · Cited by 131
Monoclonal mouse antibodies raised against human lung carcinoma
Hellstrom, I., Horn, D., Linsley, P. S., Brown, J., Brankovan, V., & Hellström, K. E. (1987) · Lung Cancer · doi:10.1016/s0169-5002(87)80426-9 · Cited by 129
Tomasi, T. B. (1968) · New England Journal of Medicine · doi:10.1056/nejm196812122792408 · Cited by 127
Shieh, D.-B., Cheng, F., Su, C., Yeh, C., Wu, M., Wu, Y., Tsai, C.-Y., Wu, C., Chen, D., & Chou, C. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.020 · Cited by 126
Self-citationRemsen, L. G., McCormick, C. I., Roman-Goldstein, S., Nilaver, G., Weissleder, R., Bogdanov, A. A., Jr., Hellström, K. E., Kroll, R. A., & Neuwelt, E. A. (1996) · PubMed Central · Cited by 123
MR imaging of phagocytosis in experimental gliomas.
Zimmer, C., Weissleder, R., Poss, K., Bogdanova, A., Wright, S. C., & Enochs, W. S. (1995) · Radiology · doi:10.1148/radiology.197.2.7480707 · Cited by 121
Porous Iron Oxide Based Nanorods Developed as Delivery Nanocapsules
Wu, P., Wang, W., Huang, Y., Sheu, H., Lo, Y., Tsai, T., Shieh, D., & Yeh, C. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200601372 · Cited by 114
Self-citationPreparation of inert magnetic nano-particles for the directed immobilization of antibodies
Fuentes, M., Mateo, C., Guisan, J. M., & Fernández‐Lafuente, R. (2004) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.06.004 · Cited by 97
Islam, T., & Josephson, L. (2009) · Cancer Biomarkers · doi:10.3233/cbm-2009-0615 · Cited by 96
Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.
Hellström, I., Beaumier, P. L., & Hellström, K. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.7059 · Cited by 91
Suwa, T., Ozawa, S., Ueda, M., Ando, N., & Kitajima, M. (1998) · International Journal of Cancer · Cited by 88
Surface‐Functionalized Nanoparticle Library Yields Probes for Apoptotic Cells
Schellenberger, E. A., Reynolds, F., Weissleder, R., & Josephson, L. (2004) · ChemBioChem · doi:10.1002/cbic.200300713 · Cited by 86
Targeting and Cellular Trafficking of Magnetic Nanoparticles for Prostate Cancer Imaging
Serda, R. E., Adolphi, N. L., Bisoffi, M., & Sillerud, L. O. (2007) · Molecular Imaging · doi:10.2310/7290.2007.00025 · Cited by 76
Toma, A., Otsuji, E., Kuriu, Y., Okamoto, K. K., Ichikawa, D., Hagiwara, A., Ito, H., Nishimura, T., & Yamagishi, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602668 · Cited by 75
Clinical issues in antibody design
Chester, K. A., & Hawkins, R. E. (1995) · Trends in biotechnology · doi:10.1016/s0167-7799(00)88968-4 · Cited by 75
Targeted folic acid‐PEG nanoparticles for noninvasive imaging of folate receptor by MRI
Chen, T., Cheng, T., Hung, Y., Lin, K., Liu, G., & Wang, Y. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31752 · Cited by 74
Engineering antibodies for imaging and therapy
Carter, P. M., & Merchant, A. M. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80067-5 · Cited by 68
Biomedical microdevices synthesis of iron oxide nanoparticles using a microfluidic system
Lee, W.-B., Weng, C.-H., Cheng, F., Yeh, C., Lei, H.-Y., & Lee, G. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9221-4 · Cited by 67
Ko, I. K., Song, H., Cho, E.-J., Lee, E. S., Huh, Y., & Suh, J. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-006-9204-7 · Cited by 42
Cited by
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Wahajuddin, & Arora (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30320 · Cited by 1,117
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,075
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Danhier, F., Le Breton, A., & Préat, V. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002733 · Cited by 955
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
Arami, H., Khandhar, A., Liggitt, D., & Krishnan, K. M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00541h · Cited by 830
Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances
Revia, R. A., & Zhang, M. (2016) · Materials Today · doi:10.1016/j.mattod.2015.08.022 · Cited by 612
Metadata
- Authors
- Rosen, J. E., Chan, L., Shieh, D.-B., & Gu, F. X.
- Venue
- Nanomedicine: Nanotechnology, Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 8
- Issue
- 3
- Pages
- 275-290
- ISSN
- 1549-9634 (ISSN-L)
- OpenAlex
- W2088014532
- Cited by
- 329
- References
- 119
- FWCI
- 14.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.